Cite

HARVARD Citation

    Takagi, T. et al. (2018). Durable response after discontinuation of nivolumab therapy in patients with metastatic renal cell carcinoma. Japanese journal of clinical oncology. pp. 860-863. [Online]. 
  
Back to record